Profilo
Michael Krams worked as the Vice President-Adaptive Trials at Wyeth LLC.
He then served as the Head-Quantitative Sciences at Janssen Pharmaceuticals, Inc. from 2013 to 2022.
Currently, he is the Chief Quantitative Medicine Officer at Exscientia Plc.
Dr. Krams holds a doctorate degree from Ludwig-Maximilians-Universität München.
Precedenti posizioni note di Michael Krams
| Società | Posizione | Fine |
|---|---|---|
| EXSCIENTIA PLC | Direttore Tecnico/Scientifico/R&S | 06/06/2024 |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | 01/02/2022 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Corporate Officer/Principal | - |
Formazione di Michael Krams
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Ludwig-Maximilians-Universität München
Ludwig-Maximilians-Universität München Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Exscientia Plc
Exscientia Plc Packaged SoftwareTechnology Services Function as an investment holding company whose subsidiaries provides artificial intelligence and machine learning services | Technology Services |
















